A review paper demonstrated that patients with such lymphoid proliferations may develop circulating anti-C1-INH autoantibodies or increased consumption of the inhibitor, producing functional deficiency and recurrent bradykinin-mediated angioedema [9]. This evidence concerns the gene SERPING1 and angioedema.